F

Amicus Therapeutics
D

FOLD

6.03000
USD
-0.15
(-2.43%)
مغلق
حجم التداول
0
الربح لكل سهم
-0
العائد الربحي
-
P/E
-67
حجم السوق
1,856,823,834
أصول ذات صلة
C
CRSP
0.050
(0.12%)
41.360 USD
E
EDIT
-0.20500
(-9.45%)
1.96500 USD
G
GLPG
-0.120
(-0.42%)
28.760 USD
N
NTLA
-0.04000
(-0.48%)
8.31000 USD
P
PTCT
0.260
(0.51%)
51.210 USD
S
SGMO
-0.02290
(-4.55%)
0.48010 USD
S
SRPT
-1.080
(-2.90%)
36.170 USD
المزيد
الأخبار المقالات

العنوان: Amicus Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants;a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.